Chromosome changes in human cancer - Are they pointers to mechanisms of initiation?

Radiation Oncology Investigations

Volumn 5, Issue 3, 1997, Pages 97-102

  Tawn, E Janet ^a  

^a WESTLAKES RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Cancer; Chromosome abnormalities; Proto oncogene; Tumour suppressor genes

Indexed keywords

CANCER GENETICS; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; ENVIRONMENTAL RADIOACTIVITY; GENE MUTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTO ONCOGENE; RADIATION CARCINOGENESIS; T LYMPHOCYTE RECEPTOR GENE; TUMOR SUPPRESSOR GENE;

ALLELES; CHIMERA; CHROMOSOME ABERRATIONS; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOMES; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, IMMUNOGLOBULIN; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMANS; MUTAGENS; MUTATION; NEOPLASMS; PROTO-ONCOGENES; RADIATION EFFECTS; RECEPTORS, ANTIGEN, T-CELL; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0030793326     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1997)5:3<97::AID-ROI2>3.0.CO;2-D     Document Type: Conference Paper

References (16)

1. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293, 1973.
2. Mitelman F: Catalog of Chromosome Aberrations in Cancer, 5th Ed. New York: Wiley-Liss, Inc., 1994.
3. Rowley JD, Mitelman F: Principles of molecular cell biology of cancer: Chromosome abnormalities in human cancer and leukaemia. In DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 4th Ed. Philadelphia: JB Lippincott Co., pp 67-91, 1993.
4. Rabbitts TH: Chromosome translocations in human cancer. Nature 372:143-149, 1994.
5. Heim S, Mitelman F: Cancer Cytogenetics, 2nd Ed. New York: Wiley-Liss, Inc., 1995.
6. Sandberg AA, Chen Z: Cancer cytogenetics and molecular genetics: Detection and therapeutic strategy. In Vivo 8:807-818, 1994.
7. Weinberg RA: Tumour suppressor genes. Science 254: 1138-1146, 1991.
8. Heisterkamp N, Groffen J: Molecular insights into the Philadelphia translocation. Hematol Pathol 5:1-10, 1991.
9. Fernandes RS, Gorman AM, McGahon A, Lawlor M, McCann S, Cotter TG: The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia. Leukaemia 10(Suppl 2):17-21, 1996.
10. Sowerby SJ, Kennedy MA, Fitzgerald PH, Morris CM: DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukaemias. Oncogene 8:1678-1683, 1993.
11. Czepulkowski BH: Malignancy and acquired chromosome abnormalities. In Rooney DE, Czepulkowski BH (eds): Human Cytogenetics: Essential Data. Chichester: John Wiley and Sons, pp 17-39, 1994.
12. Canaani E, Novvell PC, Croce CM: Molecular genetics of 11q23 chromosome translocations. Adv Cancer Res 66:213-234, 1995.
13. Bernard OA, Berger R: Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosom Cancer 13:75-85, 1995.
14. de Thé G: The etiology of Burkitt's lymphoma and the history of the shaken dogmas. Blood Cells 19:667-673, 1993.
15. Fearon ER, Vogelstein B: A genetic model of colorectal tumorigenesis. Cell 61:759-767, 1990.
16. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, et al: Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosom Cancer 12:173-185, 1995.